Members Login
    Remember Me  
Post Info TOPIC: Liquid Biopsy Market Production, Growth, Share, Demand and Applications Forecast to 2027

Veteran Member

Status: Offline
Posts: 74
Liquid Biopsy Market Production, Growth, Share, Demand and Applications Forecast to 2027

Market Highlights:

This striking growth will be accompanied by a noteworthy CAGR of 28% during the forecast period. Liquid biopsy Market Report is a plasma genotyping technique that provides overview of karyotypic abnormalities in the circulating tumor cells present in the blood sample. In simple words, it is a test done on a blood sample to look for cancer cells from a tumor circulating in the blood.

Drivers and restraints:

High success rate of diagnosis to fuel demand for liquid biopsy

Over the course of time, liquid biopsy has been estimated to become the first line of diagnosis for a broad range of cancers such as central nervous system (CNS) and pancreatic cancer. With rapid enhancements in next-generation sequencing (NGS) technology, liquid biopsies are projected to take prime position in the context of cancer-related probe and investigation.

The global market for liquid biopsy has been positively influenced by increasing cancer awareness and incidences. Alongside growing awareness is the growth of medical tourism along with modernization of healthcare infrastructure. Favorable government policies and initiatives assist the market to tread its way upward.

High cost of liquid biopsy to curb the market growth:

The market experts understand that the market is soaring high on the back of these factors, however high cost associated with liquid biopsy can be an impeding factor in the future. On the other hand, technological advancement to augment market revenues and availability of funding for liquid biopsy research and development (R&D) has given the market size a considerable thrust in the right direction. For instance, a team of researchers at Washington University, St. Louis is trying to develop a way to detect brain tumor through a blood test using liquid biopsy and the technique is completely non-invasive, adding to its appeal.

Major Players of Global liquid biopsy market:

The major participants of this market are: Guardant Health, Inc., Trovagene, Inc., RainDance Technologies, Inc., Agena Bioscience Inc. Inc., Admera Health, Biocept, Inc., Circulogene Theranostics, Inivata Ltd., SAGA Diagnostics AB, Exosome Diagnostics and others.

Request Free Sample Copy at:

Other market drivers for the liquid biopsy market size are rising rates of cancer, growing investment in research and development, collaborations between companies and public organizations, rise in geriatric population, rising expenditure on health etc. The factors which are inhibiting the growth of the market includes the prohibitive costs associated with liquid biopsy and the differential awareness and availability between developing and the developed world. However, not all cancer patients benefit from early detection as some cancer types such as brain cancer and prostate cancer may lie dormant for many years. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.

Also, the technique is not applicable to all types of cancer as some cancers such as brain cancer and prostate cancer may lie dormant for many years, and thus are either undetectable or detected very late which robs liquid biopsy of its advantages. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.

Regional Analysis:

Depending on geographic region, Liquid biopsy market size is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Liquid biopsy. Europe is the second-largest market for liquid biopsy. The developing regions market such as Asia pacific region and Middle East & Africa however is rising much faster.


Global Liquid Biopsy market size has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centres and others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071


Page 1 of 1  sorted by
Quick Reply

Please log in to post quick replies.

Tweet this page Post to Digg Post to

Create your own FREE Forum
Report Abuse
Powered by ActiveBoard